One notable development is the identification of phosphodiesterase 3A (PDE3A) gene mutations that enhance enzyme activity and are associated with hypertension with brachydactyly (HTNB) (129, 130). This evidence concerns the gene PDE3A and brachydactyly-arterial hypertension syndrome.